Philippe Willems1, Steven Weekx2, Anissa Meskal2, Sofie Schouwers2. 1. Department of Laboratory Medicine, GZA Hospitals, Wilrijk, Belgium. willemsphilippe@hotmail.com. 2. Department of Laboratory Medicine, GZA Hospitals, Wilrijk, Belgium.
Abstract
INTRODUCTION: The measurement of chloride and sodium concentrations in sweat is an important test for the diagnosis of cystic fibrosis (CF). The aim of this study was to assess the analytical variation (CVA) and within-subject (CVI) and between-subject (CVG) biological variation of chloride and sodium concentrations in sweat, collected by pilocarpine iontophoresis and to determine their effect on the clinical interpretation of sweat test results. METHODS: Twelve Caucasian adults (six male and six female) without symptoms suggestive for CF and with a mean age of 41 years (range 28-59) were included in the study. At least eight samples of sweat were collected from each individual by pilocarpine iontophoresis. Chloride and sodium concentrations were measured in duplicate for each sample using ion selective electrodes. After the removal of outliers, the CVA, CVI, and CVG of chloride and sodium were determined, and their impact on measurement uncertainty and reference change value were calculated. RESULTS: The CVA, CVI, and CVG of chloride in sweat samples were 6.5, 17.7, and 47.2%, respectively. The CVA, CVI, and CVG of sodium sweat samples were 6.0, 17.5, and 42.6%, respectively. CONCLUSION: Our study indicates that sweat chloride and sodium concentration results must be interpreted with great care. Different components of variation, particularly the biological variations, have a considerable impact on the interpretation of these results. If no pre-analytical, analytical, or post-analytical errors are suspected, repeated sweat testing to confirm first-measurement results might not be desirable.
INTRODUCTION: The measurement of chloride and sodium concentrations in sweat is an important test for the diagnosis of cystic fibrosis (CF). The aim of this study was to assess the analytical variation (CVA) and within-subject (CVI) and between-subject (CVG) biological variation of chloride and sodium concentrations in sweat, collected by pilocarpine iontophoresis and to determine their effect on the clinical interpretation of sweat test results. METHODS: Twelve Caucasian adults (six male and six female) without symptoms suggestive for CF and with a mean age of 41 years (range 28-59) were included in the study. At least eight samples of sweat were collected from each individual by pilocarpine iontophoresis. Chloride and sodium concentrations were measured in duplicate for each sample using ion selective electrodes. After the removal of outliers, the CVA, CVI, and CVG of chloride and sodium were determined, and their impact on measurement uncertainty and reference change value were calculated. RESULTS: The CVA, CVI, and CVG of chloride in sweat samples were 6.5, 17.7, and 47.2%, respectively. The CVA, CVI, and CVG of sodium sweat samples were 6.0, 17.5, and 42.6%, respectively. CONCLUSION: Our study indicates that sweat chloride and sodium concentration results must be interpreted with great care. Different components of variation, particularly the biological variations, have a considerable impact on the interpretation of these results. If no pre-analytical, analytical, or post-analytical errors are suspected, repeated sweat testing to confirm first-measurement results might not be desirable.
Entities:
Keywords:
Biological variation; Chloride; Pilocarpine iontophoresis; Sodium; Sweat; Sweat test
Authors: Carmen Perich; Joana Minchinela; Carmen Ricós; Pilar Fernández-Calle; Virtudes Alvarez; María Vicenta Doménech; Margarita Simón; Carmen Biosca; Beatriz Boned; José Vicente García-Lario; Fernando Cava; Pilar Fernández-Fernández; Callum G Fraser Journal: Clin Chem Lab Med Date: 2015-02 Impact factor: 3.694
Authors: Da-elene van der Merwe; Johan B Ubbink; Rhena Delport; Piet Becker; Gurdeep S Dhatt; W J Hayward Vermaak Journal: Ann Clin Biochem Date: 2002-01 Impact factor: 2.057
Authors: Avantika Mishra; Ronda Greaves; Katherine Smith; John B Carlin; Andrew Wootton; Rob Stirling; John Massie Journal: J Pediatr Date: 2008-06-27 Impact factor: 4.406
Authors: Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell Journal: J Pediatr Date: 2008-08 Impact factor: 4.406
Authors: Joseph M Collaco; Scott M Blackman; Karen S Raraigh; Harriet Corvol; Johanna M Rommens; Rhonda G Pace; Pierre-Yves Boelle; John McGready; Patrick R Sosnay; Lisa J Strug; Michael R Knowles; Garry R Cutting Journal: Am J Respir Crit Care Med Date: 2016-12-01 Impact factor: 21.405
Authors: J Stuart Elborn; Scott C Bell; Susan L Madge; Pierre-Regis Burgel; Carlo Castellani; Steven Conway; Karleen De Rijcke; Birgit Dembski; Pavel Drevinek; Harry G M Heijerman; J Alistair Innes; Anders Lindblad; Bruce Marshall; Hanne V Olesen; Andreas L Reimann; Ampara Solé; Laura Viviani; Thomas O F Wagner; Tobias Welte; Francesco Blasi Journal: Eur Respir J Date: 2015-10-09 Impact factor: 16.671
Authors: Tyler R Ray; Maja Ivanovic; Paul M Curtis; Daniel Franklin; Kerem Guventurk; William J Jeang; Joseph Chafetz; Hannah Gaertner; Grace Young; Steve Rebollo; Jeffrey B Model; Stephen P Lee; John Ciraldo; Jonathan T Reeder; Aurélie Hourlier-Fargette; Amay J Bandodkar; Jungil Choi; Alexander J Aranyosi; Roozbeh Ghaffari; Susanna A McColley; Shannon Haymond; John A Rogers Journal: Sci Transl Med Date: 2021-03-31 Impact factor: 17.956